ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets

Vaccines against SARS-CoV-2 are likely to be critical in the management of the ongoing pandemic. A number of candidates are in Phase III human clinical trials, including ChAdOx1 nCoV-19 (AZD1222), a replication-deficient chimpanzee adenovirus-vectored vaccine candidate. In preclinical trials, the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsh, Glenn A., McAuley, Alexander J., Au, Gough G., Riddell, Sarah, Layton, Daniel, Singanallur, Nagendrakumar B., Layton, Rachel, Payne, Jean, Durr, Peter A., Bender, Hannah, Barr, Jennifer A., Bingham, John, Boyd, Victoria, Brown, Sheree, Bruce, Matthew P., Burkett, Kathie, Eastwood, Teresa, Edwards, Sarah, Gough, Tamara, Halpin, Kim, Harper, Jenni, Holmes, Clare, Horman, William S. J., van Vuren, Petrus Jansen, Lowther, Suzanne, Maynard, Kate, McAuley, Kristen D., Neave, Matthew J., Poole, Timothy, Rootes, Christina, Rowe, Brenton, Soldani, Elisha, Stevens, Vittoria, Stewart, Cameron R., Suen, Willy W., Tachedjian, Mary, Todd, Shawn, Trinidad, Lee, Walter, Duane, Watson, Naomi, Drew, Trevor W., Gilbert, Sarah C., Lambe, Teresa, Vasan, S. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110954/
https://www.ncbi.nlm.nih.gov/pubmed/33972565
http://dx.doi.org/10.1038/s41541-021-00315-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110954/
https://www.ncbi.nlm.nih.gov/pubmed/33972565
http://dx.doi.org/10.1038/s41541-021-00315-6

Ejemplares similares